Virtual Library

Start Your Search

Jesme Fox



Author of

  • +

    ES05 - Collaboration Between Stakeholders to Improve Lung Cancer Research (ID 773)

    • Event: WCLC 2018
    • Type: Educational Session
    • Track: Advocacy
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/25/2018, 15:15 - 16:45, Room 205 AC
    • +

      ES05.03 - Discrepancies and Sustainable Access to Innovative Therapies: Transforming Patient Experience in to Patient Voice (ID 11372)

      15:55 - 16:15  |  Presenting Author(s): Jesme Fox

      • Abstract

      Abstract not provided

  • +

    MA07 - Towards Survivorship: The Landscape, Supports and Barriers (ID 904)

    • Event: WCLC 2018
    • Type: Mini Oral Abstract Session
    • Track: Advocacy
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/24/2018, 13:30 - 15:00, Room 205 AC
    • +

      MA07.03 - Attitudes to Lung Cancer in Europe: Findings from a Global Consumer Survey (ID 12579)

      13:40 - 13:45  |  Presenting Author(s): Jesme Fox

      • Abstract
      • Presentation
      • Slides

      Background

      If lung cancer is diagnosed early, patients’ chances of successful treatment are increased. Stigma
      around lung cancer, as a tobacco-related cancer, can discourage patients from talking to their doctor
      about potential symptoms. In 2017, the GLCC commissioned Populus to undertake an international
      consumer survey in each of the 25 countries of the GLCC members.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      1,000 adults, in 16 European countries, participated via an online survey in July 2017. To assess
      attitudes to lung cancer, they were told that lung cancer is mainly caused by smoking and other
      tobacco products. They were then asked the extent to which they agreed or disagreed with the
      statement: “I have less sympathy for people with lung cancer than for people with other cancers.”

      4c3880bb027f159e801041b1021e88e8 Result

      One in five (20%) people in Europe agreed that they have less sympathy for people with lung cancer
      than other forms of cancer (Chart 1). There was variation between countries with 30% of people in
      Portugal agreeing they have less sympathy in comparison to only 17% agreeing in Denmark, the
      Netherlands, Norway, Russia, Slovenia and Spain. Men in Europe are generally less sympathetic
      than women, and those aged over 55 are most sympathetic. In addition, there was a statistically
      significant correlation between those countries with lower cigarette consumption and people agreeing
      that they have less sympathy for people with lung cancer.

      Chart 1: European attitudes to lung cancer

      glcc - european attitudes - chart 1.png

      8eea62084ca7e541d918e823422bd82e Conclusion

      Everyone - no matter what the cause of their cancer - deserves to have high quality treatment and
      care. The persistent and varied levels of stigma associated with lung cancer across Europe needs to
      be addressed, so that people experiencing symptoms are not discouraged from seeking early
      intervention.

      6f8b794f3246b0c1e1780bb4d4d5dc53

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • +

    P1.02 - Advocacy (Not CME Accredited Session) (ID 934)

    • Event: WCLC 2018
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
    • +

      P1.02-11 - Lung Cancer Symptom Awareness: Findings from a Global Consumer Survey (ID 12919)

      16:45 - 18:00  |  Author(s): Jesme Fox

      • Abstract
      • Slides

      Background

      Diagnosed early, lung cancer outcomes are more positive. Absent national screening programs, symptom recognition is critical. In 2017, the Global Lung Cancer Coalition (GLCC) commissioned Populus to undertake an international consumer survey of symptom awareness in each of the 25 member countries.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      In July 2017, 1,000 adults, in each of 25 countries, were asked (unprompted) to name as many symptoms of lung cancer as they could. Findings were analysed to determine any correlation between symptom awareness and country income, using World Bank data.

      4c3880bb027f159e801041b1021e88e8 Result

      There was no correlation between the country’s income and symptom awareness (Figure 1). Four out of ten people (42%) were unable to name any symptoms of lung cancer. On average, people could only name one or two symptoms of lung cancer. The three most commonly named symptoms were coughing (38%), shortness of breath (35%) and coughing up more blood, spit or phlegm (15%).

      figure 1 average number of symptoms mentioned.png

      8eea62084ca7e541d918e823422bd82e Conclusion

      No country has room for complacency on lung cancer symptom awareness, irrespective of country income. Approaches in countries with higher symptom recognition, like Mexico, should be examined for lessons. More must to be done to reach and educate those who cannot name any symptoms of lung cancer to encourage symptom recognition and earlier presentation.

      6f8b794f3246b0c1e1780bb4d4d5dc53

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.